NeuroSense Therapeutics Enters Binding Term Sheet to Advance PrimeC for ALS

Go back to NeuroSense Therapeutics Enters Binding Term Sheet to Advance PrimeC for ALS
(NASDAQ: NRSN) Delayed: 0.38 --0 (-0%)
Previous Close $0.38    52 Week High
Open $0.38    52 Week Low
Day High $0.38    P/E N/A 
Day Low $0.38    EPS
Volume 32